Urinary Albumin-to-Creatinine Ratio, Cardiovascular Health, and All-Cause Mortality in Hypertension: A Nationwide

Dingding Wang1,2, Meng Zhang1,2, Peichen Xie1,2

  • 1Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.

Insights

Poor cardiovascular health and elevated urinary albumin-to-creatinine ratio (UACR) significantly increase mortality risk in hypertensive adults. Even mild UACR elevation is linked to higher mortality, with UACR mediating cardiovascular health

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Epidemiology

Background:

  • Cardiovascular health (CVH) and urinary albumin-to-creatinine ratio (UACR) are known mortality predictors.
  • Their combined prognostic impact and interplay in hypertension are not well understood.

Purpose of the Study:

  • To investigate the independent, combined, and mediating effects of CVH and UACR on all-cause mortality in hypertensive adults.
  • To assess the prognostic significance of integrating renal and cardiovascular metrics.

Main Methods:

  • Cohort study of 9154 hypertensive adults from NHANES 2007-2018.
  • CVH assessed by Life's Essential 8 score; UACR measured from spot urine.
  • Statistical analyses included Cox models, spline analyses, joint modeling, and causal mediation analysis.

Main Results:

  • Lower CVH and higher UACR were independently associated with increased mortality.
  • Highest mortality risk observed in individuals with severely elevated UACR and poor CVH (HR=6.61).
  • Even mildly elevated UACR (10-29.9 mg/g) significantly increased mortality; UACR mediated 4.01% of the CVH-mortality association.

Conclusions:

  • UACR modifies and mediates the association between CVH and mortality in hypertensive individuals.
  • Integrating renal (UACR) and cardiovascular metrics enhances mortality prediction.
  • Low-grade albuminuria holds significant clinical relevance for mortality risk in hypertension.

Related Concept Videos

Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
354
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
178
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
254
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
525
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
173
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K